Dupixent may help some people with inadequately controlled COPD who have a type of lung inflammation that worsens symptoms.

As COPD progresses, breathing becomes more difficult. Although lung damage cannot be reversed, its symptoms can be managed with a change in lifestyle and prescription. The severity of these two ...

The National Medical Products Administration approved Dupixent as an add-on maintenance treatment for adults with ...

5 Since COPD is a progressive disease, symptoms often evolve over time, and it’s important for patients to monitor and effectively communicate changes and the impact of symptoms to their doctor. For ...

The FDA approved dupilumab today as the first biologic treatment for patients with uncontrolled chronic obstructive pulmonary ...

China NMPA approves Sanofi & Regeneron’s Dupixent as an add-on maintenance treatment for adults with uncontrolled COPD: Paris Monday, September 30, 2024, 11:00 Hrs [IST] The Nat ...

Changes in people’s voices recoded on a smartphone can signal a serious flare up in symptoms of chronic obstructive pulmonary ...

Regeneron Pharmaceuticals, Inc. (REGN) and Sanofi (SNY), Friday announced that the U.S. Food and Drug Administration has approved ...

Approval follows EU approval of Dupixent for adults with COPD with raised blood eosinophils, and is based on two landmark Phase 3 trials showing ...

Dupixent is the first biologic medicine approved in the U.S. for the common lung condition, though competitors from GSK, AstraZeneca and Roche could follow.

Data support OhtuvayreTM (ensifentrine), as a first-in-class, selective, dual inhibitor of PDE3 and PDE4 in a broad COPD populationLONDON a ...

The following is a summary of “Virtual reality for COPD exacerbation: A randomized controlled trial,” published in the August ...